Water-soluble fatty acid derivatives as acylating agents for reversible lipidization of polypeptides
- PMID: 7556611
- DOI: 10.1016/0014-5793(95)00910-2
Water-soluble fatty acid derivatives as acylating agents for reversible lipidization of polypeptides
Abstract
A novel method allowing the conjugation of a fatty acid to a peptide or protein in aqueous buffer is described in this paper. L-Cysteinyl 2-pyridyl disulfide (CPD) (III), which was obtained by reacting L-cysteine (I) with 2,2-dithiopyridine (II), was reacted with the N-hydroxysuccinimide ester of palmitic acid (IV) to yield a water-soluble derivative of palmitic acid, termed Pal-CPD (V). Pal-CPD (V) could be reacted with a sulfhydryl-containing peptide or protein in aqueous buffer to yield the palmitic acid-derivatized conjugate (VI). The palmitic acid-derivatized Bowman-Birk protease inhibitor (BBI), synthesized using this conjugation method, was demonstrated to have 140-fold higher uptake into Caco-2 cell monolayers compared to native-BBI. The biological activity of the conjugate, as assessed using an in vitro transformation assay, was retained.
Similar articles
-
Comparison of pharmacokinetic parameters of a polypeptide, the Bowman-Birk protease inhibitor (BBI), and its palmitic acid conjugate.Pharm Res. 1996 Sep;13(9):1373-7. doi: 10.1023/a:1016078118033. Pharm Res. 1996. PMID: 8893277
-
Acylation of Bowman-Birk soybean proteinase inhibitor by unsaturated fatty acid derivatives.Biochemistry (Mosc). 2001 Apr;66(4):444-8. doi: 10.1023/a:1010209715005. Biochemistry (Mosc). 2001. PMID: 11403653
-
Bowman-Birk protease inhibitor and its palmitic acid conjugate prevent 7,12-dimethylbenz[a]anthracene-induced transformation in cultured mouse mammary glands.Cancer Lett. 2001 Mar 26;164(2):135-41. doi: 10.1016/s0304-3835(01)00381-0. Cancer Lett. 2001. PMID: 11179827
-
The biochemical and functional food properties of the bowman-birk inhibitor.Crit Rev Food Sci Nutr. 2008 Jan;48(1):94-118. doi: 10.1080/10408390601177589. Crit Rev Food Sci Nutr. 2008. PMID: 18274967 Review.
-
Peptide mimics of the Bowman-Birk inhibitor reactive site loop.Biopolymers. 2002;66(2):79-92. doi: 10.1002/bip.10228. Biopolymers. 2002. PMID: 12325158 Review.
Cited by
-
Chemically modified peptides and proteins - critical considerations for oral delivery.Tissue Barriers. 2016 Mar 3;4(2):e1156805. doi: 10.1080/21688370.2016.1156805. eCollection 2016 Apr-Jun. Tissue Barriers. 2016. PMID: 27358754 Free PMC article. Review.
-
Comparison of pharmacokinetic parameters of a polypeptide, the Bowman-Birk protease inhibitor (BBI), and its palmitic acid conjugate.Pharm Res. 1996 Sep;13(9):1373-7. doi: 10.1023/a:1016078118033. Pharm Res. 1996. PMID: 8893277
-
Self-Nano-Emulsifying Drug-Delivery Systems: From the Development to the Current Applications and Challenges in Oral Drug Delivery.Pharmaceutics. 2020 Dec 9;12(12):1194. doi: 10.3390/pharmaceutics12121194. Pharmaceutics. 2020. PMID: 33317067 Free PMC article. Review.
-
Fatty acids as therapeutic auxiliaries for oral and parenteral formulations.Adv Drug Deliv Rev. 2013 Oct;65(10):1331-9. doi: 10.1016/j.addr.2012.07.012. Epub 2012 Aug 17. Adv Drug Deliv Rev. 2013. PMID: 22921839 Free PMC article. Review.
-
Peptide Lipidation - A Synthetic Strategy to Afford Peptide Based Therapeutics.Adv Exp Med Biol. 2017;1030:185-227. doi: 10.1007/978-3-319-66095-0_9. Adv Exp Med Biol. 2017. PMID: 29081055 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources